Spectrum of Pseudomonas Aeruginosa Sensitivity in Chronic Otitis Media
DOI:
https://doi.org/10.52206/jsmc.2019.9.2.%25pKeywords:
Chronic otitis media, Microbiology in otitis media, Antibiotic sensitivity.Abstract
Background: Chronic otitis media is perforation of tympanic membrane with infection. It is mostly seen in underdeveloped
countries. Culture and sensitivity reports show that the major pathogens responsible for chronic otitis media are pseudomonas
aeruginosa and staphylococcus aureus.
Objective: To ascertain the sensitivity of Pseudomonas Aeruginosa in chronic otitis media which will help in the selection of
antibiotics in resistant cases of chronic otitis media.
Materials and Method: This prospective cross sectional study including 150 patients was carried at PNS Shifa Hospital, Karachi
from 20/04/2017 to 05/01/2018.Pus sample/swab was collected via pre-packed sterile cotton sticks for bacteriology and sent to
consultant microbiologist for culture and sensitivity. Laboratory reports of the bacterial spectrum and their sensitivity to antibiotics
were reviewed and data entered in the proforma was analyzed.
Results: After processing 36.6% pseudomonas aeruginosa infections were sensitive to Piperacillin + tazobactam while 60.98%
sensitive to ciprofloxacin, 34.15% to Amikacin and 31.71% only to Ceftriaxone. There is no significant correlation of pseudomonas
aeruginosa with duration of disease, residential status, education and socioeconomic status while significant correlation was found
with three antibiotics except ceftriaxone sodium.
Conclusion: In chronic otitis media the commonest agent being implicated is Pseudomonas aeruginosa. Ciprofloxacin, Amikacin
and pipercillin+tazobectum were found to be the most sensitive antibiotic agents against Pseudomonas aeruginosa.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.



